AU2002347102A1 - Means for inhibition of the synthesis of viral proteins - Google Patents
Means for inhibition of the synthesis of viral proteinsInfo
- Publication number
- AU2002347102A1 AU2002347102A1 AU2002347102A AU2002347102A AU2002347102A1 AU 2002347102 A1 AU2002347102 A1 AU 2002347102A1 AU 2002347102 A AU2002347102 A AU 2002347102A AU 2002347102 A AU2002347102 A AU 2002347102A AU 2002347102 A1 AU2002347102 A1 AU 2002347102A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibition
- synthesis
- viral proteins
- viral
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010067390 Viral Proteins Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10153902 | 2001-10-25 | ||
| DE10153902.9 | 2001-10-25 | ||
| PCT/DE2002/004052 WO2003038032A2 (en) | 2001-10-25 | 2002-10-25 | Means for inhibition of the synthesis of viral proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002347102A1 true AU2002347102A1 (en) | 2003-05-12 |
Family
ID=7704423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002347102A Abandoned AU2002347102A1 (en) | 2001-10-25 | 2002-10-25 | Means for inhibition of the synthesis of viral proteins |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1439853A2 (en) |
| AU (1) | AU2002347102A1 (en) |
| DE (1) | DE20220744U1 (en) |
| WO (1) | WO2003038032A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10361944A1 (en) * | 2003-12-31 | 2005-07-28 | Viromics Gmbh | Agent for inhibiting virus replication by regulating protein folding |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2095926T5 (en) * | 1990-11-02 | 2001-02-16 | Novartis Ag | CYCLOSPORINS |
| CA2248192A1 (en) * | 1996-03-12 | 1997-09-18 | Picower Institute For Medical Research | Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| US7108988B2 (en) * | 2001-11-02 | 2006-09-19 | The J. David Gladstone Institutes | Methods of identifying agents for inhibiting lentivirus replication |
-
2002
- 2002-10-25 EP EP02782752A patent/EP1439853A2/en not_active Ceased
- 2002-10-25 DE DE20220744U patent/DE20220744U1/en not_active Expired - Lifetime
- 2002-10-25 WO PCT/DE2002/004052 patent/WO2003038032A2/en not_active Ceased
- 2002-10-25 AU AU2002347102A patent/AU2002347102A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE20220744U1 (en) | 2004-05-13 |
| WO2003038032A8 (en) | 2003-08-14 |
| EP1439853A2 (en) | 2004-07-28 |
| WO2003038032A3 (en) | 2003-10-30 |
| WO2003038032A2 (en) | 2003-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002363005A1 (en) | Derivatives of uk-2a | |
| AU2002329994A1 (en) | Process for the synthesis of pyrazolopyrimidines | |
| AU2003293363A1 (en) | Process for the synthesis of bisphenol | |
| HUP0401600A3 (en) | Process for the preparation of 14-hydroxymorphine derivatives | |
| AU2002300166A1 (en) | Process for the Preparation of Peptides | |
| SG120874A1 (en) | Process for the preparation of peptides | |
| AU2003260983A1 (en) | Processes for the preparation of s-(-)-amlodipine | |
| AU2002316593A1 (en) | Solid phase synthesis of arylretinamides | |
| AU2001277728A1 (en) | Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof | |
| AU2002255897A1 (en) | Ensemble-based strategy for the design of protein pharmaceuticals | |
| AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
| AU2002337601A1 (en) | Process for the preparation of simvastatin | |
| AU2002347102A1 (en) | Means for inhibition of the synthesis of viral proteins | |
| AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
| AU2003224327A1 (en) | Process for the synthesis of peptides | |
| AU2002324291A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
| AU2002342414A1 (en) | Novel processes for the preparation of adenosine compounds and intermediates thereto | |
| AU2002360409A1 (en) | Methods and intermediates for the synthesis of azepines | |
| AUPR255201A0 (en) | Multi-launcher for sonobuoys | |
| AU2002222316A1 (en) | Process for the preparation of zafirlukast | |
| AU2002344813A1 (en) | Methods for synthesizing substituted pyrimidines | |
| AU2002352424A1 (en) | Solution-phase process for the manufacture of decapeptide | |
| AU3515700A (en) | Process for the synthesis of dihydropyridones | |
| AU2002317699A1 (en) | Improved synthesis of allofuranose | |
| AU2002232061A1 (en) | Compositions having improved bioavailability of eletriptan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |